Samjin Pharm (005500) — Capital Reinvestment Ratio
Samjin Pharm (005500) has a Capital Reinvestment Ratio of 0.36x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩10.63 Billion) in capital expenditures (₩3.78 Billion). Check tangible equity quality of Samjin Pharm to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Samjin Pharm Capital Reinvestment Ratio (2013–2024)
This chart tracks Samjin Pharm's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see 005500 cash flow metrics.
Annual Capital Reinvestment Ratio for Samjin Pharm (2013–2024)
Year-by-year Capital Reinvestment Ratio for Samjin Pharm from 2013 to 2024. See 005500 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | ₩38.15 Billion | ₩18.34 Billion | ▼ -80.7% |
| 2023 | 2.49x | ₩8.33 Billion | ₩20.72 Billion | ▲ +21.1% |
| 2022 | 2.05x | ₩17.29 Billion | ₩35.50 Billion | ▼ -34.1% |
| 2021 | 3.11x | ₩23.97 Billion | ₩74.60 Billion | ▲ +142.7% |
| 2020 | 1.28x | ₩23.86 Billion | ₩30.60 Billion | ▲ +151.7% |
| 2019 | 0.51x | ₩23.63 Billion | ₩12.04 Billion | ▲ +86.1% |
| 2018 | 0.27x | ₩30.08 Billion | ₩8.24 Billion | ▲ +15.2% |
| 2017 | 0.24x | ₩37.28 Billion | ₩8.86 Billion | ▲ +48.3% |
| 2016 | 0.16x | ₩48.66 Billion | ₩7.80 Billion | ▼ -60.4% |
| 2015 | 0.40x | ₩18.94 Billion | ₩7.66 Billion | ▼ -1.8% |
| 2014 | 0.41x | ₩32.41 Billion | ₩13.35 Billion | ▼ -55.5% |
| 2013 | 0.93x | ₩7.37 Billion | ₩6.83 Billion | — |